EMEA (Europe, Middle East and Africa) Nimodipine Market Report 2017
  • Published Date: 22-Aug-17 | Pages: 104
  • Single User: 4000 USD | Enterprice Wide License: 8000 USD

  • Description

    In this report, the EMEA Nimodipine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

    Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nimodipine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

    EMEA Nimodipine market competition by top manufacturers/players, with Nimodipine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sun Pharm Inds
    Heritage Pharms
    Bionpharma
    Arbor Pharms
    Thepharmanetwork
    Sofgen Pharms
    Bayer Vital GmbH

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Capsule
    Solution
    Tablets

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Nimodipine for each application, including
    Hospital
    Pharmacy
    Clinics


    Research Methodology

    QY Reports in their recently published report, have emphasized upon the unique and key findings of the industry for a particular assessment period. The report mainly categorizes the custom market survey conducted by the experts to collect high-quality data analysis and visualization to bring out the various dynamics of the industry. It offers a detailed information about the latest updates such as several new technological advancements made, mergers and acquisitions, new entrants in the market, which make an impact on different segments of the industry.

    Segmental Analysis

    The global industry has been segmented on the basis of its products, regions, end users, technology, applications and cues for positioning, advertising & communication strategies. For a better understanding of the market, QY Reports has also provided a detailed analysis of drivers, restraints, and opportunities that dominate the present market scenario and also provides the anticipation of the future status of this industry.

    QY Reports emphasizes on the essentials of analyzing qualitative and quantitative aspects of the industry. While giving a brief idea about the revenue opportunities for all the segments, this report has also provided the impact of industry expertise to determine the scope of the study for all the segments over the predicted period.

    Regional Analysis

    The report comprises of the geographical landscape of the industry and is briefly segmented into key regions such as North America, the Asia Pacific, Latin America, and the Middle East and Africa. Our research methodology also focuses on understanding the niche countries such as Vietnam, Indonesia, Thailand, Malaysia, Mexico, and Italy to give lucid essence of the country-wide acceptance and growth of this industry. It also provides the reader with extensive data related to the market thus, empowering them to make informed decisions about doing business.

    Our infallible research methodology offers flexibility to suit varying budgets, deadlines, and altering market dynamics. Our researches cover a detailed comprehension of a wide spectrum of products and services, along with the business strategies adopted by the new entrants who are trying to establish themselves in the competitive landscape. The market size and revenue generated by each segments has been analyzed with the help of Basis Point Share technique, which accurately calculates the percentage change in the value of trending products.

    QY Reports is committed to offer a targeted market view in order to eliminate redundant information for the complete satisfaction of thereader.

    Various sales channels such as Original Equipment Manufacturers and aftermarkets across various key regions are covered in this report.

    Our quantitative research approach identifies the market size and how much it might be worth to find areas for sales growth. It also helps the reader understand the demographics of customers, such as their gender and age. The qualitative research renders a better understanding of the customer requirements and identifies opportunities for enhancing sales and also improving customer service.

    Our research experts have focused on to offer a detailed description of the supply side of the business before placing the product in the market. The syndicated research covers critical aspects of market research to generate useful strategies that ensure accurate analysis, high-level data integrity, and impeccable forecasts. On-demand customization or bespoke proposals are rendered to exactly meet the customer needs. The information provided regarding the geographical segmentation and the competitive landscape is based on the study done on the authenticated data from direct observations, online surveys, government agencies, industry bodies, and expert interviews.

    QY Reports offers market attractiveness, which presents a market index to help the clients and target audiences recognize the numerous opportunities that the industry holds.

    In order to authenticate the data, our experts have interviewed the industry experts on various panels across the globe who have sufficient experience and knowledge related to the field. QY Reports has used frameworks such as Year on Year growth forecast, parent market overview for data analysis, and the performance of various macroeconomic factors. Also, the analysts have gathered all the necessary information from the annual reports of various companies, their official websites, and some paid publications in order to offer full-proof reports to our clients.

    The report has developed a time-bound strategic roadmap for the readers by weaving different aspects of business into a winning fabric.


    Table of Contents

    EMEA (Europe, Middle East and Africa) Nimodipine Market Report 2017
    1 Nimodipine Overview
    1.1 Product Overview and Scope of Nimodipine
    1.2 Classification of Nimodipine
    1.2.1 EMEA Nimodipine Market Size (Sales) Comparison by Type (2012-2022)
    1.2.2 EMEA Nimodipine Market Size (Sales) Market Share by Type (Product Category) in 2016
    1.2.3 Capsule
    1.2.4 Solution
    1.2.5 Tablets
    1.3 EMEA Nimodipine Market by Application/End Users
    1.3.1 EMEA Nimodipine Sales (Volume) and Market Share Comparison by Application (2012-2022
    1.3.2 Hospital
    1.3.3 Pharmacy
    1.3.4 Clinics
    1.4 EMEA Nimodipine Market by Region
    1.4.1 EMEA Nimodipine Market Size (Value) Comparison by Region (2012-2022)
    1.4.2 Europe Status and Prospect (2012-2022)
    1.4.3 Middle East Status and Prospect (2012-2022)
    1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Nimodipine (2012-2022)
    1.5.1 EMEA Nimodipine Sales and Growth Rate (2012-2022)
    1.5.2 EMEA Nimodipine Revenue and Growth Rate (2012-2022)

    2 EMEA Nimodipine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Nimodipine Market Competition by Players/Manufacturers
    2.1.1 EMEA Nimodipine Sales Volume and Market Share of Major Players (2012-2017)
    2.1.2 EMEA Nimodipine Revenue and Share by Players (2012-2017)
    2.1.3 EMEA Nimodipine Sale Price by Players (2012-2017)
    2.2 EMEA Nimodipine (Volume and Value) by Type/Product Category
    2.2.1 EMEA Nimodipine Sales and Market Share by Type (2012-2017)
    2.2.2 EMEA Nimodipine Revenue and Market Share by Type (2012-2017)
    2.2.3 EMEA Nimodipine Sale Price by Type (2012-2017)
    2.3 EMEA Nimodipine (Volume) by Application
    2.4 EMEA Nimodipine (Volume and Value) by Region
    2.4.1 EMEA Nimodipine Sales and Market Share by Region (2012-2017)
    2.4.2 EMEA Nimodipine Revenue and Market Share by Region (2012-2017)
    2.4.3 EMEA Nimodipine Sales Price by Region (2012-2017)

    3 Europe Nimodipine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Nimodipine Sales and Value (2012-2017)
    3.1.1 Europe Nimodipine Sales Volume and Growth Rate (2012-2017)
    3.1.2 Europe Nimodipine Revenue and Growth Rate (2012-2017)
    3.2 Europe Nimodipine Sales and Market Share by Type
    3.3 Europe Nimodipine Sales and Market Share by Application
    3.4 Europe Nimodipine Sales Volume and Value (Revenue) by Countries
    3.4.1 Europe Nimodipine Sales Volume by Countries (2012-2017)
    3.4.2 Europe Nimodipine Revenue by Countries (2012-2017)
    3.4.3 Germany Nimodipine Sales and Growth Rate (2012-2017)
    3.4.4 France Nimodipine Sales and Growth Rate (2012-2017)
    3.4.5 UK Nimodipine Sales and Growth Rate (2012-2017)
    3.4.6 Russia Nimodipine Sales and Growth Rate (2012-2017)
    3.4.7 Italy Nimodipine Sales and Growth Rate (2012-2017)
    3.4.8 Benelux Nimodipine Sales and Growth Rate (2012-2017)

    4 Middle East Nimodipine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Nimodipine Sales and Value (2012-2017)
    4.1.1 Middle East Nimodipine Sales Volume and Growth Rate (2012-2017)
    4.1.2 Middle East Nimodipine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Nimodipine Sales and Market Share by Type
    4.3 Middle East Nimodipine Sales and Market Share by Application
    4.4 Middle East Nimodipine Sales Volume and Value (Revenue) by Countries
    4.4.1 Middle East Nimodipine Sales Volume by Countries (2012-2017)
    4.4.2 Middle East Nimodipine Revenue by Countries (2012-2017)
    4.4.3 Saudi Arabia Nimodipine Sales and Growth Rate (2012-2017)
    4.4.4 Israel Nimodipine Sales and Growth Rate (2012-2017)
    4.4.5 UAE Nimodipine Sales and Growth Rate (2012-2017)
    4.4.6 Iran Nimodipine Sales and Growth Rate (2012-2017)

    5 Africa Nimodipine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Nimodipine Sales and Value (2012-2017)
    5.1.1 Africa Nimodipine Sales Volume and Growth Rate (2012-2017)
    5.1.2 Africa Nimodipine Revenue and Growth Rate (2012-2017)
    5.2 Africa Nimodipine Sales and Market Share by Type
    5.3 Africa Nimodipine Sales and Market Share by Application
    5.4 Africa Nimodipine Sales Volume and Value (Revenue) by Countries
    5.4.1 Africa Nimodipine Sales Volume by Countries (2012-2017)
    5.4.2 Africa Nimodipine Revenue by Countries (2012-2017)
    5.4.3 South Africa Nimodipine Sales and Growth Rate (2012-2017)
    5.4.4 Nigeria Nimodipine Sales and Growth Rate (2012-2017)
    5.4.5 Egypt Nimodipine Sales and Growth Rate (2012-2017)
    5.4.6 Algeria Nimodipine Sales and Growth Rate (2012-2017)

    6 EMEA Nimodipine Manufacturers/Players Profiles and Sales Data
    6.1 Sun Pharm Inds
    6.1.1 Company Basic Information, Manufacturing Base and Competitors
    6.1.2 Nimodipine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
    6.1.3 Sun Pharm Inds Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.1.4 Main Business/Business Overview
    6.2 Heritage Pharms
    6.2.1 Company Basic Information, Manufacturing Base and Competitors
    6.2.2 Nimodipine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
    6.2.3 Heritage Pharms Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.2.4 Main Business/Business Overview
    6.3 Bionpharma
    6.3.1 Company Basic Information, Manufacturing Base and Competitors
    6.3.2 Nimodipine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
    6.3.3 Bionpharma Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.3.4 Main Business/Business Overview
    6.4 Arbor Pharms
    6.4.1 Company Basic Information, Manufacturing Base and Competitors
    6.4.2 Nimodipine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
    6.4.3 Arbor Pharms Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.4.4 Main Business/Business Overview
    6.5 Thepharmanetwork
    6.5.1 Company Basic Information, Manufacturing Base and Competitors
    6.5.2 Nimodipine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
    6.5.3 Thepharmanetwork Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.5.4 Main Business/Business Overview
    6.6 Sofgen Pharms
    6.6.1 Company Basic Information, Manufacturing Base and Competitors
    6.6.2 Nimodipine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
    6.6.3 Sofgen Pharms Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.6.4 Main Business/Business Overview
    6.7 Bayer Vital GmbH
    6.7.1 Company Basic Information, Manufacturing Base and Competitors
    6.7.2 Nimodipine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
    6.7.3 Bayer Vital GmbH Nimodipine Sales, Revenue, Price and Gross Margin (2012-2017)
    6.7.4 Main Business/Business Overview

    7 Nimodipine Manufacturing Cost Analysis
    7.1 Nimodipine Key Raw Materials Analysis
    7.1.1 Key Raw Materials
    7.1.2 Price Trend of Key Raw Materials
    7.1.3 Key Suppliers of Raw Materials
    7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.2.1 Raw Materials
    7.2.2 Labor Cost
    7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nimodipine

    8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nimodipine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nimodipine Major Manufacturers in 2016
    8.4 Downstream Buyers

    9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
    9.1.1 Direct Marketing
    9.1.2 Indirect Marketing
    9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
    9.2.1 Pricing Strategy
    9.2.2 Brand Strategy
    9.2.3 Target Client
    9.3 Distributors/Traders List

    10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
    10.1.1 Substitutes Threat
    10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

    11 EMEA Nimodipine Market Forecast (2017-2022)
    11.1 EMEA Nimodipine Sales, Revenue and Price Forecast (2017-2022)
    11.1.1 EMEA Nimodipine Sales and Growth Rate Forecast (2017-2022)
    11.1.2 EMEA Nimodipine Revenue and Growth Rate Forecast (2017-2022)
    11.1.3 EMEA Nimodipine Price and Trend Forecast (2017-2022)
    11.2 EMEA Nimodipine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Nimodipine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Nimodipine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Nimodipine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Nimodipine Sales Forecast by Type (2017-2022)
    11.7 EMEA Nimodipine Sales Forecast by Application (2017-2022)

    12 Research Findings and Conclusion

    13 Appendix
    13.1 Methodology/Research Approach
    13.1.1 Research Programs/Design
    13.1.2 Market Size Estimation
    13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
    13.2.1 Secondary Sources
    13.2.2 Primary Sources
    13.3 Disclaimer